Saudi Pharmaceutical Industries and Medical Appliances Corporation (SASE:2070) agreed to acquire 68% stake in Osmopharm SA for SAR 16.1 million on November 14, 2023. The transaction s expected to be completed in the first half of 2024, contingent on regulatory approvals. Olha Demianiuk and Dr. Alexander Wyss of Baker & McKenzie acted as legal advisor to Saudi Pharmaceutical Industries and Medical Appliances Corporation.
Saudi Pharmaceutical Industries and Medical Appliances Corporation
Equities
2070
SA0007879188
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.5 SAR | -1.22% | -5.19% | -3.44% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.44% | 1.18B | |
+25.58% | 661B | |
+26.74% | 566B | |
-6.60% | 352B | |
+19.45% | 332B | |
+3.52% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.85% | 145B |
- Stock Market
- Equities
- 2070 Stock
- News Saudi Pharmaceutical Industries and Medical Appliances Corporation
- Saudi Pharmaceutical Industries and Medical Appliances Corporation agreed to acquire 68% stake in Osmopharm SA for SAR 16.1million.